Dergiler / Turkish Journal of Gastroenterology / 2016 / Cilt: 27 - Sayı: 2

A rapid test for assessing disease activity in ulcerative colitis

Sayfa
149–155
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Nevertheless, in monitoring patients, combined determination of the three inflammatory markers studied [C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), calprotectin] is more useful in reducing unnecessary colonoscopies

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: Direct assessment by endoscopic examination has become a "gold standard" in monitoring patients with ulcerative colitis.
📊
Temel Bulgular & Veri:The aim is therefore to identify a less invasive method of assessing ulcerative colitis activity compared to colonoscopy.Materials and Methods: A prospective study was conducted among 103 patients with ulcerative colitis.
💡
Sonuç & Katkı:Nevertheless, in monitoring patients, combined determination of the three inflammatory markers studied [C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), calprotectin] is more useful in reducing unnecessary colonoscopies
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: Direct assessment by endoscopic examination has become a "gold standard" in monitoring patients with ulcerative colitis. However, it is an invasive method, with risks and discomfort for the patients. The aim is therefore to identify a less invasive method of assessing ulcerative colitis activity compared to colonoscopy.Materials and Methods: A prospective study was conducted among 103 patients with ulcerative colitis. Calprotectin was measured by a semi-quantitative rapid test. For each patient, a complete blood count was performed; liver and kidney functions, glycaemia, serum proteins, and inflammatory markers were also evaluated.Results: The Mayo score showed direct correlations with fecal calprotectin, C-reactive protein, and the erythrocyte sedimentation rate (p<0.05) and indirect correlations with hemoglobin (p=0.139). The sensitivity and specificity of calprotectin were 98.0% and 76.7%, respectively. Subsequently, combined analysis of the markers' sensitivity/specificity was conducted.Conclusion: The semi-quantitative rapid test proved to be a good predictor for differentiating the endoscopic active disease from the inactive one. The individual use of fecal calprotectin presents the highest sensitivity in determining the endoscopic activity. Nevertheless, in monitoring patients, combined determination of the three inflammatory markers studied [C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), calprotectin] is more useful in reducing unnecessary colonoscopies

🔖

Bu Makaleye Atıf Yap

DRANGA, M., MİHAİ, C., DRUG, V., DUMİTRESCU, G., PRELİPCEAN, C. C. (2016). A rapid test for assessing disease activity in ulcerative colitis. Turkish Journal of Gastroenterology, Cilt: 27 - Sayı: 2, 149–155. https://ajindex.com/articles/411310

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Bamias G, Kaltsa G, Ladas SD. Cytokines in the pathogenesis of ulcerative colitis. Discovery Medicine 2011
  2. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ul- cerative colitis. Lancet 2012
  3. [CrossRef] Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Do- bos GJ. Noninvasive markers in the assessment of intestinal in- flammation in inflammatory bowel diseases: performance of fe- cal lactoferrin, calprotectin, and PMN-Elastase, CRP, and Clinical Indice. Am J Gastroenterol 2008
  4. [CrossRef] Vermeire S, Van Assche G, Rutgeerts P. C-Reactive Protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis 2004
  5. [CrossRef] Solem CA, Loftus EV, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Correlation of C-reactive protein with clinical, en- doscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005
  6. [CrossRef] Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys. Gut 2006
  7. [CrossRef] Gabay C, Kushner I. Acute phase reactants and other systemic re- sponses to inflammation. N Engl J Med 1999
  8. [CrossRef] Sachar DB, Smith H, Chan S, Cohen LB, Lichtiger S, Messer J. Erythro- cytic sedimentation rate as a measure of clinical activity in inflamma- tory bowel disease. J Clin Gastroenterol 1986
  9. [CrossRef] Osada T, Ohkusa T, Okayasu I, et al. Correlation among total colono- scopic findings, clinical symptoms, and laboratory markers in ulcer- ative colitis. J Gastroenterol Hepatol 2008
  10. S262-7. [CrossRef] Gasche C, Lomer MCE, Cavill I, Weiss G. Iron, anemia, and inflam- matory bowel diseases. Gut 2004
  11. [CrossRef] Kopylov U, Rosenfeld G, Bressler B, Seidman E. Clinical utility of fe- cal biomarkers for the diagnosis and management of inflammatory bowel disease. Inflamm Bowel Dis 2014
  12. [CrossRef] Yoon JJ, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Correlation of C-reactive protein levels and erythrocyte sedimentation rates with endoscopic indices in patients with ulcerative colitis. Dig Dis Sci 2014
  13. [CrossRef] Xiang JY, Ouyang Q, Li GD, Xiao NP. Clinical value of fecal calpro- tectin in determining disease activity of ulcerative colitis. World J Gastroenterol 2008
  14. [CrossRef] Hİivik ML, Reinisch W, Cvancarova M, Moum B
  15. IBSEN study group. Anemia in inflammatory bowel disease: a population-based 10-year fo